ADCT: Nilai perusahaan marang bathi resik ADC Therapeutics S.A.

ADC Therapeutics (ADCT) complies with hazardous waste disposal standards and laboratory energy efficiency. High barriers to entry are driven by the high cost of conjugate development and patent law. Historical price action on GURU.Markets recorded a value of -2.10. The business's financial success relies on global shipments of ZYNLONTA, designed for the therapy of specific forms of lymphoma, which serves as the primary cash generator.

ADCT - Rasio rega marang bathi adctherapeutics.com ing rentang 04.07.2022 - 14.11.2026

Rincian analitis perusahaan ADC Therapeutics

- rega saham lan prakiraan rega para ahli:

Bagan owah-owahan rega ADC Therapeutics Corp|ADCT - Target konsensus

- informasi kapitalisasi pasar:

Nilai pasar ADC Therapeutics S.A.|ADCT - Nilai Perusahaan

- indikator nilai aset resik miturut neraca:

Aset Bersih saben Siji Saham ADC Therapeutics|ADCT - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku adctherapeutics.com|ADCT - Aset Agregat Perusahaan

- informasi babagan utang lan solvabilitas:

Utang marang Modal ADC Therapeutics|ADCT - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal ADC Therapeutics|ADCT - Gunggung utang perusahaan|Rasio utang marang nilai buku ADC Therapeutics S.A.|ADCT - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan ADC Therapeutics|Rasio likuiditas darurat adctherapeutics.com

- statistik bathi lan rasio pasar:

ADCT - Bathi resik|Bathi mangsa ngarep ADC Therapeutics|ADCT - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi ADC Therapeutics|ADCT - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan ADC Therapeutics S.A.|ADCT - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku ADC Therapeutics|ADCT - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan adctherapeutics.com|ADCT - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep ADC Therapeutics

- indikator volume dodolan lan pendapatan:

ADCT - Pendapatan lan volume dodolan|Prakiraan volume dodolan ADC Therapeutics S.A.|ADCT - Rasio rega marang pendapatan|Rega mangsa ngarep marang pendapatan ADC Therapeutics S.A.

Ringkesan analisis perusahaan:ADC Therapeutics SA ADCT

The slow integration of Zynlonta into clinical practice directly impacts the P/E ratio of ADC Therapeutics (ADCT). This ratio is calculated by dividing the share price by net income to determine the investment payback period. Amid high capital burn and secondary offerings, this metric reveals the extent of the premium paid for future success. It is critical for investors to benchmark this indicator against product commercialization rates to assess risks.

Pesaing wigati